EDIT:NASDAQ, Editas Medicine, Inc.

EDIT stock overview

Editas Medicine, Inc. (EDIT:NASDAQ) closed at $2.28 on October 14, 2026, down 6.95% on the day. The stock trades 47.5% below its 52-week high of $4.33 and 37.0% above its 52-week low of $1.66. Over the past year, it lost 31.9%. Editas Medicine, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).

Key figures

Price
$2.28
Day change
-6.95%
Volume
1,195,744
Average volume
2,502,718
Market cap
349M+
52-week range
$1.66 – $4.33
50-day average
$2.85
200-day average
$2.65

Performance

5D 1M 3M 6M 1Y
-15.69% -10.77% -15.10% -29.94% -31.89%

Price action over the past year

In 252 trading sessions since October 13, 2025, EDIT closed higher on 115 days (46%). Its best day was March 9, 2026 (+16.00%) and its worst was June 2, 2026 (-15.57%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

EDIT news

About Editas Medicine, Inc.

Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.

Similar stocks

Find more stocks like EDIT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.